Filter your results
- 3
- 3
- 3
- 1
- 1
- 1
- 3
- 3
- 2
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
IL4I1: an inhibitor of the CD8(+) antitumor T-cell response in vivo.European Journal of Immunology, 2011, 41 (6), pp.1629-38. ⟨10.1002/eji.201041119⟩
Journal articles
inserm-00604898v1
|
||
|
Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferationOncotarget, 2014, pp.25294815
Journal articles
inserm-01078327v1
|
||
|
What role for AHR activation in IL4I1-mediated immunosuppression ?OncoImmunology, 2021, 10 (1), pp.1924500. ⟨10.1080/2162402X.2021.1924500⟩
Journal articles
hal-03244910v1
|